Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells
Authors
Keywords
Phosphates, Cervical cancer, Enzyme inhibitors, Cancer cell migration, Enzyme assays, Hydrolysis, HeLa cells, Keratinocytes
Journal
PLoS One
Volume 10, Issue 7, Pages e0134305
Publisher
Public Library of Science (PLoS)
Online
2015-07-30
DOI
10.1371/journal.pone.0134305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Basic Red 51, a permitted semi-permanent hair dye, is cytotoxic to human skin cells: Studies in monolayer and 3D skin model using human keratinocytes (HaCaT)
- (2014) Thalita B. Zanoni et al. TOXICOLOGY LETTERS
- Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
- (2012) Ivana Z Matic et al. BMC IMMUNOLOGY
- Molecularly targeted therapies in cervical cancer. A systematic review
- (2012) Flora Zagouri et al. GYNECOLOGIC ONCOLOGY
- Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity
- (2012) Petr Busek et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor
- (2012) Aiying Wang et al. BMC Pharmacology & Toxicology
- Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors
- (2011) Aleksandra Erić-Nikolić et al. IMMUNOBIOLOGY
- Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas
- (2010) Loretta De Chiara et al. BMC CANCER
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
- (2009) Mark Kirby et al. CLINICAL SCIENCE
- CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL
- (2009) Lilla Cro et al. HEMATOLOGICAL ONCOLOGY
- CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia
- (2009) Camilla F. C. G. de Andrade et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The In Vivo Expression of Dipeptidyl Peptidases 8 and 9
- (2009) Denise M.T. Yu et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines
- (2008) MARIUSZ ADAM GOSCINSKI et al. APMIS
- Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype
- (2008) Patricia de Cremoux et al. INTERNATIONAL JOURNAL OF CANCER
- Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation
- (2008) W T Arscott et al. ONCOGENE
- The role of CD26/dipeptidyl peptidase IV in cancer
- (2007) Pamela et al. Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now